EU authorizes third adapted COVID-19 vaccine for Autumn campaigns
The European Medicines Agency (EMA) carried out an in-depth evaluation of the vaccine. Following this evaluation, the Commission authorised the…
The European Medicines Agency (EMA) carried out an in-depth evaluation of the vaccine. Following this evaluation, the Commission authorised the…
The presidency of the Council and European Parliament negotiators reached a provisional agreement on a regulation to modernise and simplify…
As autumn season approaches, the European Medicines Agency (EMA) and the European Centre for Disease...
The European Medicines Agency (EMA) carried out a stringent evaluation of the vaccine under the accelerated assessment mechanism. Following this evaluation, the…
The reflection paper is part of the joint HMA-EMA Big Data Steering Group (BDSG) initiatives to develop the European Medicines…
The European Commission, the Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA) are today issuing recommendations for…
The presidency and the Commission informed delegations about the negotiations for an international agreement on pandemic prevention, preparedness and response as well…
The proposed regulation aims to update the existing legislation governing fees charged by EMA. It will ensure that fees and remuneration…
News 06/06/2023 The European Centre for Disease Prevention and Control (ECDC) and the European Medicines Agency...
News 28/03/2023 DARWIN EU®, the Data Analysis and Real-World Interrogation Network, has accomplished its first year...
Stockholm/Amsterdam, 8 December 2022 The European Medicines Agency (EMA) and the European Centre for Disease...
Table of contents Event summary Live broadcast – 09:00-17:55 Amsterdam time (CET) Documents Related content...
Brussels, 24 October 2022 Today, the Council has adopted the final building blocks of the European...
Brussels, 21 September 2022 On 20-21 September, a delegation of the special committee on COVID-19...
Solna, 6 September 2022 The European Centre for Disease Prevention and Control (ECDC) and the...
Brussels, 1 September 2022 Today, the European Medicines Agency (EMA) has given a positive opinion...
Brussels, 19 August 2022 Today, the European Medicines Agency (EMA) has advised on intradermal use of monkeypox...
11 Jul 2022 The European Centre for Disease Prevention and Control (ECDC) and the European...
Brussels, 4 Jul 2022 Today, Member States have given their support to the establishment of...
6 April 2022 The European Centre for Disease Prevention and Control (ECDC) and EMA’s COVID-19...
31 January 2022 As of tomorrow, 1 February, the new rules start applying on a...
Brussels, 28 January 2022 As of Monday 31 January, the assessment and supervision of clinical trials throughout...
Brussels, 25 January 2022 Today, as part of the on-going work to build a strong...
20.01.2022 Europeans are likely to be better protected from medicine shortages during health crises after...
Better crisis preparedness and management for medicinal products and medical devices New EU platform to...
13/01/2022 On 12 January, regulators from around the world discussed the global regulatory response to...
13/01/2022 Today, the European Commission (EC), the Heads of Medicines Agencies (HMA) and the European Medicines Agency...
Amsterdam, 6/12/2021 The European Medicines Agency’s (EMA) human medicines committee (CHMP) has recommended extending the indication of RoActemra...
03/12/2021 The International Coalition of Medicines Regulatory Authorities (ICMRA) and the World Health Organization (WHO) have reviewed some of...
News 02/12/2021 EMA’s human medicines committee (CHMP) has started a rolling review of VLA2001, a...
MEPs will quiz EMA Executive Director Emer Cooke on the latest developments regarding COVID-19 vaccines...
EU better equipped to manage future health crises after COVID-19 lessons learned More effective in...
Today, the EU Council presidency and European Parliament negotiators reached a provisional agreement on a...
Brussels, 28 October 2021 Today, the European Parliament and the Council reached a political agreement...
Answer given by Ms Kyriakides on behalf of the European Commission (27.8.2021) 1. By concluding...
Today, the European Commission has approved its seventh Advanced Purchase Agreement (APA) with a pharmaceutical...
With the increasing circulation of the Delta variant of SARS-CoV-2 in EU/EEA countries, the European Medicines Agency...
The use of antibiotics has decreased and is now lower in food-producing animals than in...
A stronger European Medicine Agency (EMA) with a reinforced transparency, participation, coordination and prevention –...
The Council has reached an agreement on draft rules to reinforce the role of the...
15 June 2021, 12:45 The Council has reached an agreement on draft rules to reinforce...
See question(s) : E-001513/2021 Source : © European Union, 2021 – EP Source: Answer to...
The European Medicines Agency has today started the rolling review of sotrovimab (VIR-7831), a monoclonal antibody developed...
News 20/04/2021 EMA confirms overall benefit-risk remains positive At its meeting of 20 April 2021,...
Today, as an immediate action under the HERA Incubator, the new European bio-defence preparedness plan...
MEPs will quiz EMA Executive Director Emer Cooke on the latest developments regarding the evaluation...
On Monday, Members of the Environment, Public Health and Food Safety Committee debated with experts...
MEPs will address their questions to experts on COVID-19 variants and the vaccines’ efficacy against...
DRAFT OPINION on the proposal for a regulation of the European Parliament and of the...